跳至主要内容
临床试验/IRCT20220603055066N1
IRCT20220603055066N1招募中未知

Comparative evaluation of PRP (Platelet-Rich Plasma) with nutritional supplements in improvement of hair loss (telogen effluvium) in patients recovered from COVID-19 in Bam Pasteur hospital in 2022

Bam University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
All

入选标准

  • Age 20 to 50 years
  • Covid 19 disease (positive by PCR test) 2 to 4 months before enrollment
  • Occurrence of persistent and significant hair loss after Covid 19 disease, which according to the diagnosis of a dermatologist has a pattern similar to telogen effluvium

排除标准

  • People who are diagnosed as the other types of alopecia (except telogen effluvium)
  • Pregnant or lactating women
  • Patients who are being treated with drugs such as finasteride, spironolactone, minoxidil or OCP or who have recently stopped taking these drugs
  • Patients who have an underlying disease affecting hair loss
  • Lack of informed consent to enter the study

研究者

发起方
Bam University of Medical Sciences

相似试验